{"id":432531,"date":"2021-02-10T04:03:09","date_gmt":"2021-02-10T09:03:09","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=432531"},"modified":"2021-02-10T04:03:09","modified_gmt":"2021-02-10T09:03:09","slug":"citi-appointed-as-depositary-bank-for-immunocore-holdings-plcs-adr-programme","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/citi-appointed-as-depositary-bank-for-immunocore-holdings-plcs-adr-programme\/","title":{"rendered":"Citi Appointed as Depositary Bank for Immunocore Holdings plc\u2019s ADR Programme"},"content":{"rendered":"<p>        <!--.bwuline { text-decoration: underline }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p><b>Citi Appointed as Depositary Bank for Immunocore Holdings plc\u2019s ADR Programme<\/b><\/p>\n<p>LONDON&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nCiti, acting through Citibank N.A., has been appointed by Immunocore Holdings plc (\u201cImmunocore\u201d), a late-stage biotechnology company, to act as depositary bank for its American Depositary Receipt (\u201cADR\u201d) programme.\n<\/p>\n<p>\nImmunocore\u2019s American Depositary Shares (\u201cADS\u201d) trade on the Nasdaq Global Market under the symbol \u201cIMCR\u201d. Each ADS represents one ordinary share of the company.\n<\/p>\n<p>\nCommenting on the appointment, Dirk Jones, Global Head of Issuer Services, at Citi said: \u201cWe look forward to supporting Immunocore\u2019s ADR programme and expanding the company\u2019s investor outreach through the expertise of our Investor Relations Advisory team and the breadth of our global equity distribution network.\u201d\n<\/p>\n<p>\nFor more information on Citi\u2019s Depositary Receipt Services, please visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.citi.com%2Fdr&amp;esheet=52376530&amp;newsitemid=20210210005077&amp;lan=en-US&amp;anchor=www.citi.com%2Fdr&amp;index=1&amp;md5=7a98176f5c6c723948a7051fef855791\">www.citi.com\/dr<\/a><\/p>\n<p><b>About Immunocore<br \/>\n<br \/><\/b>Immunocore is a late-stage biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies called ImmTAX \u2013 Immune mobilizing monoclonal TCRs Against X disease \u2013 designed to treat a broad range of diseases, including cancer, infectious and autoimmune. Leveraging its proprietary, flexible, off-the-shelf ImmTAX platform, Immunocore is developing a deep pipeline in multiple therapeutic areas, including five clinical stage programs in oncology and infectious disease, advanced pre-clinical programs in autoimmune disease and multiple earlier pre-clinical programs. Immunocore\u2019s most advanced oncology therapeutic candidate, tebentafusp, has demonstrated monotherapy activity in a Phase 2 clinical trial in metastatic uveal melanoma, a cancer that has historically proven to be insensitive to other immunotherapies, and is currently being studied in an ongoing Phase 3 clinical trial.\n<\/p>\n<p>\nAdditional information may be found at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.nanobiotix.com&amp;esheet=52376530&amp;newsitemid=20210210005077&amp;lan=en-US&amp;anchor=www.Immunocore.com&amp;index=2&amp;md5=525a0b709277a207358564b88ba3617d\">www.Immunocore.com<\/a><\/p>\n<p><b>About Citi<br \/>\n<br \/><\/b>Citi, the leading global bank, has approximately 200 million customer accounts and does business in more than 160 countries and jurisdictions. Citi provides consumers, corporations, governments and institutions with a broad range of financial products and services, including consumer banking and credit, corporate and investment banking, securities brokerage, transaction services, and wealth management.\n<\/p>\n<p>\nAdditional information may be found at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.citigroup.com&amp;esheet=52376530&amp;newsitemid=20210210005077&amp;lan=en-US&amp;anchor=www.citigroup.com&amp;index=3&amp;md5=7c595a7b6b07a22f193638006558c71f\">www.citigroup.com<\/a> | Twitter: @Citi | YouTube: <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.youtube.com%2Fciti&amp;esheet=52376530&amp;newsitemid=20210210005077&amp;lan=en-US&amp;anchor=www.youtube.com%2Fciti&amp;index=4&amp;md5=23bdf03b4e6e5dc59d682cfb16716d57\">www.youtube.com\/citi<\/a> | Blog: <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fblog.citigroup.com%2F&amp;esheet=52376530&amp;newsitemid=20210210005077&amp;lan=en-US&amp;anchor=http%3A%2F%2Fblog.citigroup.com&amp;index=5&amp;md5=2775a924b9859b89982dafada4ddb605\">http:\/\/blog.citigroup.com<\/a> | Facebook: <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.facebook.com%2Fciti&amp;esheet=52376530&amp;newsitemid=20210210005077&amp;lan=en-US&amp;anchor=www.facebook.com%2Fciti&amp;index=6&amp;md5=8f8a3164ef91eee491af432937eba23b\">www.facebook.com\/citi<\/a> | LinkedIn: <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fciti&amp;esheet=52376530&amp;newsitemid=20210210005077&amp;lan=en-US&amp;anchor=www.linkedin.com%2Fcompany%2Fciti&amp;index=7&amp;md5=40bf5f51b6977f1c170ffd7640065b61\">www.linkedin.com\/company\/citi<\/a><\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210210005077r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20210210005077\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20210210005077\/en\/<\/a><\/span><\/p>\n<p><b>Citi Media Contact:<br \/>\n<br \/><\/b>Shani Halstead<br \/>\n<br \/>+44 (0) 20 7508 2352<br \/>\n<br \/><span class=\"bwuline\"><a rel=\"nofollow\" href=\"mailto:shani.halstead@citi.com\">shani.halstead@citi.com<\/a><\/span><\/p>\n<p><b>KEYWORDS:<\/b> United Kingdom Europe<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Biotechnology Finance Banking Health Professional Services<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20210210005077\/en\/386817\/3\/citi_2c-blu_pos_rgb.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Citi Appointed as Depositary Bank for Immunocore Holdings plc\u2019s ADR Programme LONDON&#8211;(BUSINESS WIRE)&#8211; Citi, acting through Citibank N.A., has been appointed by Immunocore Holdings plc (\u201cImmunocore\u201d), a late-stage biotechnology company, to act as depositary bank for its American Depositary Receipt (\u201cADR\u201d) programme. Immunocore\u2019s American Depositary Shares (\u201cADS\u201d) trade on the Nasdaq Global Market under the symbol \u201cIMCR\u201d. Each ADS represents one ordinary share of the company. Commenting on the appointment, Dirk Jones, Global Head of Issuer Services, at Citi said: \u201cWe look forward to supporting Immunocore\u2019s ADR programme and expanding the company\u2019s investor outreach through the expertise of our Investor Relations Advisory team and the breadth of our global equity distribution network.\u201d For more information on Citi\u2019s Depositary Receipt Services, &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/citi-appointed-as-depositary-bank-for-immunocore-holdings-plcs-adr-programme\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Citi Appointed as Depositary Bank for Immunocore Holdings plc\u2019s ADR Programme&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-432531","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Citi Appointed as Depositary Bank for Immunocore Holdings plc\u2019s ADR Programme - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/citi-appointed-as-depositary-bank-for-immunocore-holdings-plcs-adr-programme\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Citi Appointed as Depositary Bank for Immunocore Holdings plc\u2019s ADR Programme - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Citi Appointed as Depositary Bank for Immunocore Holdings plc\u2019s ADR Programme LONDON&#8211;(BUSINESS WIRE)&#8211; Citi, acting through Citibank N.A., has been appointed by Immunocore Holdings plc (\u201cImmunocore\u201d), a late-stage biotechnology company, to act as depositary bank for its American Depositary Receipt (\u201cADR\u201d) programme. Immunocore\u2019s American Depositary Shares (\u201cADS\u201d) trade on the Nasdaq Global Market under the symbol \u201cIMCR\u201d. Each ADS represents one ordinary share of the company. Commenting on the appointment, Dirk Jones, Global Head of Issuer Services, at Citi said: \u201cWe look forward to supporting Immunocore\u2019s ADR programme and expanding the company\u2019s investor outreach through the expertise of our Investor Relations Advisory team and the breadth of our global equity distribution network.\u201d For more information on Citi\u2019s Depositary Receipt Services, &hellip; Continue reading &quot;Citi Appointed as Depositary Bank for Immunocore Holdings plc\u2019s ADR Programme&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/citi-appointed-as-depositary-bank-for-immunocore-holdings-plcs-adr-programme\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-02-10T09:03:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210210005077r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/citi-appointed-as-depositary-bank-for-immunocore-holdings-plcs-adr-programme\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/citi-appointed-as-depositary-bank-for-immunocore-holdings-plcs-adr-programme\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Citi Appointed as Depositary Bank for Immunocore Holdings plc\u2019s ADR Programme\",\"datePublished\":\"2021-02-10T09:03:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/citi-appointed-as-depositary-bank-for-immunocore-holdings-plcs-adr-programme\\\/\"},\"wordCount\":399,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/citi-appointed-as-depositary-bank-for-immunocore-holdings-plcs-adr-programme\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210210005077r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/citi-appointed-as-depositary-bank-for-immunocore-holdings-plcs-adr-programme\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/citi-appointed-as-depositary-bank-for-immunocore-holdings-plcs-adr-programme\\\/\",\"name\":\"Citi Appointed as Depositary Bank for Immunocore Holdings plc\u2019s ADR Programme - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/citi-appointed-as-depositary-bank-for-immunocore-holdings-plcs-adr-programme\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/citi-appointed-as-depositary-bank-for-immunocore-holdings-plcs-adr-programme\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210210005077r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2021-02-10T09:03:09+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/citi-appointed-as-depositary-bank-for-immunocore-holdings-plcs-adr-programme\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/citi-appointed-as-depositary-bank-for-immunocore-holdings-plcs-adr-programme\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/citi-appointed-as-depositary-bank-for-immunocore-holdings-plcs-adr-programme\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210210005077r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210210005077r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/citi-appointed-as-depositary-bank-for-immunocore-holdings-plcs-adr-programme\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Citi Appointed as Depositary Bank for Immunocore Holdings plc\u2019s ADR Programme\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Citi Appointed as Depositary Bank for Immunocore Holdings plc\u2019s ADR Programme - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/citi-appointed-as-depositary-bank-for-immunocore-holdings-plcs-adr-programme\/","og_locale":"en_US","og_type":"article","og_title":"Citi Appointed as Depositary Bank for Immunocore Holdings plc\u2019s ADR Programme - Market Newsdesk","og_description":"Citi Appointed as Depositary Bank for Immunocore Holdings plc\u2019s ADR Programme LONDON&#8211;(BUSINESS WIRE)&#8211; Citi, acting through Citibank N.A., has been appointed by Immunocore Holdings plc (\u201cImmunocore\u201d), a late-stage biotechnology company, to act as depositary bank for its American Depositary Receipt (\u201cADR\u201d) programme. Immunocore\u2019s American Depositary Shares (\u201cADS\u201d) trade on the Nasdaq Global Market under the symbol \u201cIMCR\u201d. Each ADS represents one ordinary share of the company. Commenting on the appointment, Dirk Jones, Global Head of Issuer Services, at Citi said: \u201cWe look forward to supporting Immunocore\u2019s ADR programme and expanding the company\u2019s investor outreach through the expertise of our Investor Relations Advisory team and the breadth of our global equity distribution network.\u201d For more information on Citi\u2019s Depositary Receipt Services, &hellip; Continue reading \"Citi Appointed as Depositary Bank for Immunocore Holdings plc\u2019s ADR Programme\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/citi-appointed-as-depositary-bank-for-immunocore-holdings-plcs-adr-programme\/","og_site_name":"Market Newsdesk","article_published_time":"2021-02-10T09:03:09+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210210005077r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/citi-appointed-as-depositary-bank-for-immunocore-holdings-plcs-adr-programme\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/citi-appointed-as-depositary-bank-for-immunocore-holdings-plcs-adr-programme\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Citi Appointed as Depositary Bank for Immunocore Holdings plc\u2019s ADR Programme","datePublished":"2021-02-10T09:03:09+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/citi-appointed-as-depositary-bank-for-immunocore-holdings-plcs-adr-programme\/"},"wordCount":399,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/citi-appointed-as-depositary-bank-for-immunocore-holdings-plcs-adr-programme\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210210005077r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/citi-appointed-as-depositary-bank-for-immunocore-holdings-plcs-adr-programme\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/citi-appointed-as-depositary-bank-for-immunocore-holdings-plcs-adr-programme\/","name":"Citi Appointed as Depositary Bank for Immunocore Holdings plc\u2019s ADR Programme - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/citi-appointed-as-depositary-bank-for-immunocore-holdings-plcs-adr-programme\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/citi-appointed-as-depositary-bank-for-immunocore-holdings-plcs-adr-programme\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210210005077r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2021-02-10T09:03:09+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/citi-appointed-as-depositary-bank-for-immunocore-holdings-plcs-adr-programme\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/citi-appointed-as-depositary-bank-for-immunocore-holdings-plcs-adr-programme\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/citi-appointed-as-depositary-bank-for-immunocore-holdings-plcs-adr-programme\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210210005077r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210210005077r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/citi-appointed-as-depositary-bank-for-immunocore-holdings-plcs-adr-programme\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Citi Appointed as Depositary Bank for Immunocore Holdings plc\u2019s ADR Programme"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/432531","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=432531"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/432531\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=432531"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=432531"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=432531"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}